Bioequivalence Study of V0057 Versus a Reference Formulation After Single Administration in Healthy Male Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
45
Participants
Timeline
Start Date
May 31, 2013
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Conditions
Healthy Volunteers
Interventions
DRUG
V0057 - A mg
Single oral administration
DRUG
Isotretinoin
Single oral administration
Trial Locations (1)
D-99084
Erfurt
All Listed Sponsors
lead
Pierre Fabre Dermatology
INDUSTRY
NCT01861626 - Bioequivalence Study of V0057 Versus a Reference Formulation After Single Administration in Healthy Male Subjects | Biotech Hunter | Biotech Hunter